Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: bazedoxifene/conjugated estrogens combination

Study type: Interventional

Funder types: Industry

Identifiers

NCT00550303

3115A1-1123

Details and patient eligibility

About

The primary purpose is to determine bioavailability of Bazedoxifene/conjugated estrogen formulations for future testing purposes.

Enrollment: 28 estimated patients

Sex: Female

Ages: 45 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy, post menopausal women ages 45 to 70

Exclusion criteria

• Male subjects

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)